PMC5367451_01
Left lung atelectasis (during abraxane, last therapy session); white arrow indicates the central mass to the left main bronchus.
tcrm-13-341Fig1.jpg
PMC5367451_01_tcrm-13-341Fig1.jpg
f1-tcrm-13-341
After only 28 days of the afatinib 40 mg administration, a complete resolution of the atelectasis of the left lung was observed consistent with drug response (Figures 1-4).
Computed tomography scan of the thorax (during abraxane); the left lung is totally collapsed (white arrow).
tcrm-13-341Fig2.jpg
PMC5367451_01_tcrm-13-341Fig2.jpg
f2-tcrm-13-341
After only 28 days of the afatinib 40 mg administration, a complete resolution of the atelectasis of the left lung was observed consistent with drug response (Figures 1-4).
After 28 days under afatinib 40 mg (the mass has started to shrink and the left lung to inflate, white arrow).
tcrm-13-341Fig3.jpg
PMC5367451_01_tcrm-13-341Fig3.jpg
f3-tcrm-13-341
After only 28 days of the afatinib 40 mg administration, a complete resolution of the atelectasis of the left lung was observed consistent with drug response (Figures 1-4).
After 65 days from the afatinib 40 mg administration (white arrow indicates the part of the left lower lobe that has been inflated and red arrow indicates the central mass that used to totally block the left lung).
tcrm-13-341Fig4.jpg
PMC5367451_01_tcrm-13-341Fig4.jpg
f4-tcrm-13-341
After only 28 days of the afatinib 40 mg administration, a complete resolution of the atelectasis of the left lung was observed consistent with drug response (Figures 1-4).